Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PREGABALIN ORION HARD CAPSULE 25MG | ORION PHARMA (SG) PTE. LTD. | PREGABALIN ORION HARD CAPSULE 25MG | Jul 1, 2024 | SIN17035P |
| RIMONAL EYE DROPS 0.15% w/v | GOLDPLUS UNIVERSAL PTE LTD | RIMONAL EYE DROPS 0.15% w/v | Jun 28, 2024 | SIN17034P |
| TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML | ROCHE SINGAPORE PTE. LTD. | TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML | Jun 27, 2024 | SIN17033P |
| XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML | NOVARTIS (SINGAPORE) PTE LTD | XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML | Jun 21, 2024 | SIN17029P |
| XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML | NOVARTIS (SINGAPORE) PTE LTD | XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1.0ML | Jun 21, 2024 | SIN17031P |
| XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 75MG/0.5ML | NOVARTIS (SINGAPORE) PTE LTD | XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 75MG/0.5ML | Jun 21, 2024 | SIN17030P |
| XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 300MG/2.0ML | NOVARTIS (SINGAPORE) PTE LTD | XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED PEN 300MG/2.0ML | Jun 21, 2024 | SIN17032P |
| THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL | NYPRAX PHARMA PTE. LTD. | THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL | Jun 20, 2024 | SIN17028P |
| THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 15MG/VIAL | NYPRAX PHARMA PTE. LTD. | THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 15MG/VIAL | Jun 20, 2024 | SIN17027P |
| ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML | ASTRAZENECA SINGAPORE PTE LTD | ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML | Jun 19, 2024 | SIN17026P |
| NOVERON SOLUTION FOR INJECTION 10MG/ML | GOLDPLUS UNIVERSAL PTE LTD | NOVERON SOLUTION FOR INJECTION 10MG/ML | Jun 12, 2024 | SIN17025P |
| ARISTO-LATA Latanoprost Eye Drops 0.005% w/v | APEX PHARMA MARKETING PTE. LTD. | ARISTO-LATA Latanoprost Eye Drops 0.005% w/v | Jun 11, 2024 | SIN17024P |
| NEUROFIND PROLONGED RELEASE TABLETS 54 MG | LOTUS INTERNATIONAL PTE. LTD. | NEUROFIND PROLONGED RELEASE TABLETS 54 MG | Jun 5, 2024 | SIN17021P |
| NEUROFIND PROLONGED RELEASE TABLETS 18 MG | LOTUS INTERNATIONAL PTE. LTD. | NEUROFIND PROLONGED RELEASE TABLETS 18 MG | Jun 5, 2024 | SIN17020P |
| NEUROFIND PROLONGED RELEASE TABLETS 36 MG | LOTUS INTERNATIONAL PTE. LTD. | NEUROFIND PROLONGED RELEASE TABLETS 36 MG | Jun 5, 2024 | SIN17023P |
| NEUROFIND PROLONGED RELEASE TABLETS 27 MG | LOTUS INTERNATIONAL PTE. LTD. | NEUROFIND PROLONGED RELEASE TABLETS 27 MG | Jun 5, 2024 | SIN17022P |
| MEKINIST® POWDER FOR ORAL SOLUTION 4.7 MG | NOVARTIS (SINGAPORE) PTE LTD | MEKINIST® POWDER FOR ORAL SOLUTION 4.7 MG | Jun 3, 2024 | SIN17018P |
| TAFINLAR DISPERSIBLE TABLET 10MG | NOVARTIS (SINGAPORE) PTE LTD | TAFINLAR DISPERSIBLE TABLET 10MG | Jun 3, 2024 | SIN17019P |
| COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) | BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD. | COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) | May 31, 2024 | SIN17016P |
| COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) | BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD. | COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) | May 31, 2024 | SIN17017P |
